Regnante Keith

CIK 00016820682 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001682068

Recent Transactions

32 trades

Award
Keros Therapeutics, Inc.$KROS
Common Stock
2025-02-18+44,000→ 44,000 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2024-02-13+40,000→ 40,000 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2024-01-04$45.29/sh−40,000→ 0 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2024-01-04$16.00/sh+40,000→ 40,000 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2024-01-04−40,000→ 53,622 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2023-11-04$45.29/sh−40,000→ 0 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2023-11-04$16.00/sh+40,000→ 40,000 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2023-06-09$16.00/sh+20,000→ 20,000 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2023-06-09−20,000→ 93,622 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2023-06-09$47.25/sh−2,579→ 0 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2023-06-09$45.03/sh−15,993→ 4,007 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2023-06-09$46.46/sh−1,428→ 2,579 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2023-06-08−20,000→ 113,622 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2023-06-08$47.66/sh−17,301→ 2,699 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2023-06-08$48.65/sh−2,699→ 0 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2023-06-08$16.00/sh+20,000→ 20,000 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2023-02-16+40,000→ 40,000 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-01-21+50,000→ 50,000 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-01-10+49,150→ 49,150 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2020-04-07+18,430→ 18,430 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2020-04-07+133,622→ 133,622 total
Award
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2019-03-07+13,500→ 29,186 total
Sale
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2019-02-19$36.84/sh−1,298→ 15,686 total
Exercise/Conversion
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2018-09-24−29,500→ 90,500 total
Sale
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2018-09-24$55.00/sh−29,500→ 16,984 total
Exercise/Conversion
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2018-09-24$20.89/sh+29,500→ 46,484 total
Sale
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2018-02-16$51.85/sh−316→ 16,984 total
Award
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2018-01-23+13,000→ 17,300 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2018-01-23+26,000→ 26,000 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2017-01-25+8,600→ 8,600 total
Award
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2017-01-25+4,300→ 4,300 total
Award
Wave Life Sciences Ltd.$WVE
Share Option (right to buy)
2016-08-16+120,000→ 120,000 total

Companies

Recent Filings

Address

C/O KEROS THERAPEUTICS, INC. 1050 WALTHAM STREET, SUITE 302

LEXINGTON, MA, 02421

View on SEC.gov